Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Search
About Us
Sign in
Chemical Industry News, Data & Insights
About Us
Sign in
Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Products
WEEKLY
FOCUS
ALPHA
Innovation and Product Development news
(page 40)
22 December 2025
OMV Petrom and CE Oltenia Begin 550 MW Solar Park Construction
The solar parks will power 410,000 homes by 2026, with a EUR 400M investment. 70% is funded by the Modernisation Fund. 200 mining technicians retrained for renewable energy roles.
22 December 2025
FDA Approves Novo Nordisk's Oral Wegovy for Adult Weight Loss
FDA approves Wegovy pill, the first oral GLP-1 for weight loss, showing ~17% loss in trials. Available January at $149/month, it also reduces cardiovascular risks in adults with obesity.
22 December 2025
Novo Nordisk: FDA Approves Wegovy® Oral Pill for Weight Management
Wegovy® pill, an oral GLP-1, shows 16.6% weight loss in trials. Launch expected in the US by January 2026. Approval based on OASIS and SELECT trials.
22 December 2025
Prysmian and Versalis Innovate Plastic Cable Recycling
The partnership uses chemical recycling to convert plastic cable scrap into reusable polymers, enabling sustainable cable production and advancing circular economy efforts.
22 December 2025
Topsoe and Partners Launch Dynamic Green Ammonia Plant in Denmark
The world's first dynamic green ammonia plant in Denmark produces 5,000 tons annually, reducing CO2 by 9,600 tons, using renewable power without hydrogen storage.
22 December 2025
Roche's Lunsumio VELO Approved by FDA for Subcutaneous Use in Follicular Lymphoma
Lunsumio VELO cuts treatment time to one minute for relapsed follicular lymphoma, offering outpatient care with a manageable safety profile.
The right choices in the European chemical industry
Save time with
chemXplore Alpha
Learn more
22 December 2025
Asahi Kasei Pharma Relocates R&D Hub to Shonan iPark
The move aims to boost R&D capabilities, enhance open innovation, and attract talent by leveraging Shonan iPark's life-science ecosystem and advanced facilities.
19 December 2025
Johnson & Johnson Supports HRS Registry for PFA Data Collection
The registry will gather real-world data on PFA for AFib, aiming to improve treatment strategies and outcomes in electrophysiology.
19 December 2025
UPM's Leuna Biorefinery Begins Commercial Production of Bio-based Chemicals
The biorefinery produces industrial sugars, enabling renewable glycols and lignin fillers, supporting the shift from fossil to bio-based materials, with full operations expected by 2026.
19 December 2025
NEXTCHEM (MAIRE) Secures Urea Technology Contract in China
A new urea plant in China will use Ultra-Low Energy technology, cutting steam use by 35% and cooling water by 16%, marking its tenth global application.
18 December 2025
Solinatra and Paques Biomaterials partner to commercialise PHBV for biodegradable single‑use plastics
Joint development plan and conditional offtake to fast‑track lab-to-industrial pilots, certification and scale‑up of next‑gen biodegradable materials; validation in 2026, supply from 2028.
18 December 2025
Toray Unveils Cost-Effective Photo Definable Polyimide for Semiconductors
New polyimide sheet enables efficient microfabrication, reduces costs, and minimizes thermal stress in semiconductor manufacturing.
18 December 2025
NEXTCHEM Opens New Facility at MyReplast's Bedizzole Upcycling Plant
The new facility includes offices and a showroom showcasing the NX Replast™ upcycling process, producing 40,000 tons of recycled polymers annually with 95% efficiency.
18 December 2025
Johnson & Johnson's TRUFILL n-BCA Approved by FDA for Chronic Subdural Hematoma Treatment
FDA approves TRUFILL n-BCA for MMA embolization in chronic subdural hematoma, offering a minimally invasive alternative to surgery with proven safety and effectiveness.
18 December 2025
Lilly's Orforglipron Maintains Weight Loss in Phase 3 Trial
Orforglipron met primary and key secondary endpoints for weight maintenance at 52 weeks post-weight loss on Wegovy. FDA submission for obesity treatment is underway.
18 December 2025
Novo Nordisk Seeks FDA Approval for CagriSema, a Weekly Obesity Treatment
CagriSema, combining cagrilintide and semaglutide, shows 23% weight loss in trials. If approved, it offers a new obesity treatment option.
18 December 2025
Topsoe Chosen for Uruguay's SAF and Renewable Diesel Project
ANCAP partners with Topsoe to produce 3,000 barrels/day of SAF and renewable diesel in Uruguay by 2030, reducing CO₂ emissions by 390,000 tons annually.
18 December 2025
Novo Nordisk Seeks FDA Approval for CagriSema, a Weekly Obesity Treatment
CagriSema, a weekly injectable combining GLP-1 and amylin analogues, shows promising weight loss results in trials and awaits FDA review for obesity management.
18 December 2025
BASF and ADAMA Partner on Gilboa Fungicide for European Cereals
The partnership aims to accelerate Gilboa fungicide solutions for European cereal growers, with launches in Great Britain by 2027 and broader Europe by 2029.
18 December 2025
Aisti secures €20M EIB loan for sustainable acoustic tiles expansion
EIB loan boosts production of bio-based acoustic tiles, supporting EU green goals and rural development, while enhancing R&D for improved properties and market expansion.
18 December 2025
Neste and Cathay Group Expand Sustainable Aviation Fuel Use Globally
Neste supplies SAF to Cathay Group for flights in Europe, the U.S., and Asia-Pacific, reducing emissions by up to 80% with renewable materials like used cooking oil.
18 December 2025
Takeda's Zasocitinib Phase 3 Trials Show Promise for Plaque Psoriasis Treatment
Zasocitinib met all primary and secondary endpoints in Phase 3 trials, showing potential for clear skin in plaque psoriasis with a consistent safety profile.
17 December 2025
Taaleri and Tesi Invest EUR 16M in Ren-Gas
Ren-Gas, a Finnish P2G developer, plans a nationwide network of e-methane plants, leveraging Finland's renewable energy and grid infrastructure for emissions reduction in transport.
17 December 2025
Aptar's Bidose System Delivers FDA-Approved CARDAMYST Nasal Spray for PSVT
CARDAMYST, a self-administered nasal spray for PSVT, offers reliable, easy-to-use treatment with Aptar's protective dual-container system, enhancing drug delivery solutions.
17 December 2025
Johnson & Johnson's RYBREVANT FASPRO™ Gains FDA Approval for Faster NSCLC Treatment
FDA approves RYBREVANT FASPRO™ for EGFR-mutated NSCLC, offering faster, subcutaneous administration with fewer side effects compared to IV delivery.
17 December 2025
WITTMANN Expands Production in China
WITTMANN's Kunshan plant now produces injection molding machines locally, doubling capacity and enhancing efficiency. The site will also serve as a development hub for tailored solutions.
17 December 2025
Merck's KEYTRUDA and Padcev Enhance Survival in Cisplatin-Eligible MIBC Patients
KEYTRUDA and Padcev improve survival and response rates in MIBC patients, showing promise as perioperative treatment with consistent safety profiles.
17 December 2025
Borealis Launches AI-Driven Borstar® Digital Twin Program
The Borstar Digital Twin enhances efficiency, safety, and sustainability in production through AI, real-time monitoring, and predictive insights, marking a new phase in digital operations.
17 December 2025
Iberdrola Uses Seville-Made Solutions for German Offshore Wind Farm Protection
Transition pieces at the Windanker wind farm are coated with a cork compound to endure marine conditions, with RTS evolving to offer marine protection solutions.
17 December 2025
EIB Lends €40M to Technip Energies for R&D in Decarbonisation and Circular Economy
The loan supports R&D in clean technologies, textile recycling, and skilled job creation in Europe, aligning with EIB's climate and innovation goals.
← Previous
Next →
